Sale is live|00:00:00
Insecticides India LtdQ1 FY23

Insecticides India Ltd

Q1 FY23 Earnings Call Analysis

Management growth scorecard

Revenue

Category 3

Margin

Category 2

Fundraise

N/A

Order

N/A

Capex

Yes

1 of 3 growth signals are positive — mixed outlook.

Full analysis

Revenue guidance

Category 3
  • Targeting double-digit revenue growth of 10% to 12% in fiscal year 2024.
  • Expecting significant growth in exports, aiming to double export sales compared to the previous year.
  • Planning gross sales of over INR 800 crores in Q1, supported by new product launches and higher sales targets.
  • New patented and branded products (e.g., Shinwa, Hachiman, Torry, Mission) expected to contribute substantially, with Focused Maharatna and Maharatna segments projected to account for at least 60% of sales in FY '24.
  • Inventory liquidation and market normalization anticipated to improve margins and profitability.
  • Anticipate recovery and growth as agricultural season picks up, with positive impact expected from monsoon timing and market conditions.
  • Expansion of product portfolio and R&D initiatives aimed at sustaining growth and entering new markets continuously.

Margin guidance

Category 2
  • FY '24 expected to be challenging due to inventory liquidation and market pressures, but growth is anticipated.
  • Revenue growth target for FY '24 is double-digit, around 10%-12%.
  • EBITDA margin guidance for FY '24 is subdued at 9%-10%, with improvement expected post Q1 as lower cost inventories come into effect.
  • The company aims to increase profitability beyond current 10% EBITDA margin to 12%+ in FY '25 when market normalizes and new, higher-margin patented products gain traction.
  • New product launches, including patented products, expected to drive better margins and growth over the next few years.
  • Export growth projected to double in FY '24, potentially boosting earnings.
  • Performance is expected to improve from Q2 FY '24 onwards, assuming favorable monsoon and easing of Chinese pricing pressures.
  • Long-term growth supported by R&D, backward integration, introduction of mega brands, and new markets expansion.

Sign up free to read the full earnings analysis

Get access to all 5 sections — revenue, margin, fundraise, orderbook, and capex — for Insecticides India Ltd and 1,400+ other companies.

Fundraise plans

  • There is no mention of any current or future fundraising plans through debt or equity in the provided transcript.
  • The management did not discuss raising capital or issuing shares during the call.
  • Rajesh Aggarwal confirmed no promoter share offloading or reduction has occurred; in fact, promoter holding increased due to past buyback.
  • The focus is on internal growth through new product launches, R&D, backward integration, and improving profitability rather than external fundraising.
  • No specific financial plans involving raising capital were shared for the near future.

Order book

  • The transcript does not explicitly mention a specific current or expected order book or pending orders value.
  • Rajesh Aggarwal mentions strong sales targets, notably planning gross sales of INR 800 crores-plus in the first quarter, indicating a strong order pipeline.
  • Demand for products remains good domestically, with no significant stocks in the market, suggesting steady off-take.
  • Chinese inventory is still flowing into the market, which affects pricing but also indicates ongoing procurement and orders.
  • The company is optimistic about growth from Q2 onwards, assuming normalization post monsoon.
  • While exact order book figures aren’t disclosed, the focus on inventory liquidation and ambitious Q1 sales targets implies a healthy pending order scenario.

Capex plans

Yes
  • Completed project at Chopanki; plant is up and functioning with full-fledged technical production.
  • New molecules from Chopanki unit have already been launched in the market.
  • Announced a new plant at Sotanala (Behror); company in final stages of acquisition with registry expected in early June.
  • Plans to start production of formulations and biologicals from the new site, with technicals production as Phase 2 in a phased approach.
  • Focus on backward integration initiatives supporting business momentum and growth.

How does Insecticides India Ltd rank vs peers in Fertilizers & Agrochemicals?

Pro feature
1Insecticides India Ltd
Rev 3Mar 2

See full Fertilizers & Agrochemicals sector rankings

Unlock with Pro

Want more stocks like Insecticides India Ltd?

Build an AI portfolio filtered by sector, market cap, and growth rank. Takes 2 minutes.

Build my portfolio